FIG. 5.
Delivered doses during simulation of patient use with DuoResp Spiromax (simulation schemes shown in Table 1). Low strength: 80/4.5 μg per dose; middle strength: 160/4.5 μg per dose; high strength: 320/9 μg per dose.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.